As a result, the World Health Organization (WHO) has recently updated their guidelines to support the expanded use of the Alere TB-LAM assay in all patients hospitalized with symptoms and signs of TB, CD4 count <200 cells/μL (irrespective of symptoms), or clinically advanced HIV disease, or who are seriously ill [14] . This evidence concerns the gene CD4 and tuberculosis.